The buy-side Quality of Earnings team is insisting on shifting our historical revenue recognition from cash to accrual basis, which apparently slashes our trailing twelve months EBITDA by twenty percent. How do we defend our true cash-generation capacity and prevent a massive reduction in our purchase price?

Question

Tyler Smith · Accepted Answer

Do not panic when a buy-side Quality of Earnings firm attempts to redefine your historical performance. Their job is to find reasons to chip away at your valuation. A shift from cash to accrual accounting often creates a timing mismatch, especially if you collect upfront payments for long-term services. To defend your valuation, you must present a detailed reconciliation that separates GAAP revenue recognition from actual cash-flow dynamics. Use your historical Scorecard data to demonstrate your customer retention and cash-conversion cycle. Prove that your cash collection exceeds recognized revenue and that this cash is immediately deployable to fund operations. Work with your advisory team to build a bridge analysis. This analysis should show that the deferred revenue on your balance sheet is a highly valuable, low-risk liability because your cost to deliver the service is minimal. If the buyer still insists on using the lower accrual EBITDA for the purchase price calculation, you must adjust the deal structure. Demand that the working capital target be adjusted downward to reflect the cash you already collected. This ensures the buyer does not get both the cash and a discounted price. Remind the buyer that your operational efficiency, run on a structured Accountability Chart, minimizes delivery costs, meaning that deferred revenue is highly profitable.